Vitro SAB de CV Statistics
Vitro SAB de CV (VITOF) Stock Statistics & Valuation Metrics
Total Valuation
Vitro SAB de CV has a market cap or net worth of $129.28M. The enterprise value is $305.61T.
- Market Cap
- $129.28M
- Enterprise Value
- $305.61T
Share Statistics
Vitro SAB de CV has 483,571,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 483,571,400
- Owned by Insiders
- ―
- Owned by Institutions
- 0.09%
Financial Efficiency
Vitro SAB de CV’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 0.58%.
- Return on Equity (ROE)
- 0.21
- Return on Assets (ROA)
- 0.11
- Return on Invested Capital (ROIC)
- 0.58%
- Return on Capital Employed (ROCE)
- 0.01
- Revenue Per Employee
- 13.31K
- Profits Per Employee
- 6,116.976
- Employee Count
- 22,568
- Asset Turnover
- 0.23
- Inventory Turnover
- 10.74
Valuation Ratios
The current PE Ratio of Vitro SAB de CV is 1.11. Vitro SAB de CV’s PEG ratio is 0.02.
- PE Ratio
- 1.11
- PS Ratio
- 0.95
- PB Ratio
- 3.13
- Price to FCF
- 0.78
- Price to Operating Cash Flow
- 0.73
- PEG Ratio
- 0.02
Income Statement
In the last 12 months, Vitro SAB de CV had revenue of 300.37M and earned 138.05M in profits. Earnings per share was 0.29.
- Revenue
- 300.37M
- Gross Profit
- 109.62M
- Operating Income
- 6.20M
- Pretax Income
- 160.92M
- Net Income
- 138.05M
- EBITDA
- 33.16M
- Earnings Per Share (EPS)
- 0.29
Cash Flow
In the last 12 months, operating cash flow was 172.36M and capital expenditures -10.41M, giving a free cash flow of 161.95M billion.
- Operating Cash Flow
- 172.36M
- Free Cash Flow
- 161.95M
- Free Cash Flow per Share
- 0.34
Dividends & Yields
Vitro SAB de CV pays an annual dividend of ―, resulting in a dividend yield of 568.83%
- Dividend Per Share
- ―
- Dividend Yield
- 568.83%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 128.20%
- Earnings Yield
- 90.24%
Stock Price Statistics
- Beta
- 0.00
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.15
- 200-Day Moving Average
- 0.15
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Vitro SAB de CV upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Jul 26, 2024
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Vitro SAB de CV as a current ratio of 1.20, with Debt / Equity ratio of 23.69%
- Current Ratio
- 1.20
- Quick Ratio
- 1.16
- Debt to Market Cap
- 1.02
- Net Debt to EBITDA
- 4.07
- Interest Coverage Ratio
- 0.17
Taxes
In the past 12 months, Vitro SAB de CV has paid 22.87M in taxes.
- Income Tax
- 22.87M
- Effective Tax Rate
- 0.14
Enterprise Valuation
Vitro SAB de CV EV to EBITDA ratio is 39.29, with an EV/FCF ratio of 1.09.
- EV to Sales
- 1.33
- EV to EBITDA
- 39.29
- EV to Free Cash Flow
- 1.09
- EV to Operating Cash Flow
- 1.03
Balance Sheet
Vitro SAB de CV has $11.00M in cash and marketable securities with $62.00M in debt, giving a net cash position of -$51.00M billion.
- Cash & Marketable Securities
- $11.00M
- Total Debt
- $62.00M
- Net Cash
- -$51.00M
- Net Cash Per Share
- -$0.11
- Tangible Book Value Per Share
- $0.08
Margins
Gross margin is 52.41%, with operating margin of -11.50%, and net profit margin of 85.78%.
- Gross Margin
- 52.41%
- Operating Margin
- -11.50%
- Pretax Margin
- 45.73%
- Net Profit Margin
- 85.78%
- EBITDA Margin
- 3.40%
- EBIT Margin
- -10.75%
Analyst Forecast
The average price target for Vitro SAB de CV is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- -52.70%
- EPS Growth Forecast
- 79.72%

